PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

278 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
▮◀ ◀◀ 1 ... 2 ... 3 ... 4 ... 5 ... 6 ... 7 ... 8 ... 9 ... 10 ... 11 ... 12 ... 13 ... 14 ... ▶▶ ▶▮
Alle Publikationen dieser Seite in den Korb legen
21.
Hummel, S. ; Friedl, N. ; Winkler, C. ; Ziegler, A.-G. & Achenbach, P.: Presymptomatic type 1 diabetes and disease severity at onset. Reply to Schneider J, Gemulla G, Kiess W et al [letter]. Diabetologia 66, 2389-2390 (2023)
22.
Hummel, S. et al.: Children diagnosed with presymptomatic type 1 diabetes through public health screening have milder diabetes at clinical manifestation. Diabetologia 66, 1633-1642 (2023)
23.
Li, J.H.* et al.: Genome-wide association analysis identifies ancestry-specific genetic variation associated with acute response to metformin and glipizide in SUGAR-MGH. Diabetologia 66, 1260-1272 (2023)
24.
Lorza-Gil, E. et al.: Glucose-stimulated insulin secretion depends on FFA1 and Gq in neonatal mouse islets. Diabetologia 66, 1501-1515 (2023)
25.
Luo, H. et al.: Associations of plasma proteomics with type 2 diabetes and related traits: Results from the longitudinal KORA S4/F4/FF4 Study. Diabetologia 66, 1655-1668 (2023)
26.
Lutter, D. et al.: Skeletal muscle and intermuscular adipose tissue gene expression profiling identifies new biomarkers with prognostic significance for insulin resistance progression and intervention response. Diabetologia 66, 873-883 (2023)
27.
Marzinotto, I.* et al.: Islet Autoantibody Standardization Program: Interlaboratory comparison of insulin autoantibody assay performance in 2018 and 2020 workshops. Diabetologia 66, 897-912 (2023)
28.
Nauck, M.A.* & Müller, T.D.: Incretin hormones and type 2 diabetes. Diabetologia 66, 1780-1795 (2023)
29.
Tschöp, M.H. ; Nogueiras, R.* & Ahrén, B.*: Gut hormone-based pharmacology: Novel formulations and future possibilities for metabolic disease therapy. Diabetologia 66, 1796-1808 (2023)
30.
Wewer Albrechtsen, N.J.* et al.: 100 years of glucagon and 100 more. Diabetologia 66, 1378-1394 (2023)
31.
Ziegler, A.-G.: The countdown to type 1 diabetes: when, how and why does the clock start? Diabetologia 66, 1169-1178 (2023)
32.
Fraszczyk, E.* et al.: Epigenome-wide association study of incident type 2 diabetes: A meta-analysis of five prospective European cohorts. Diabetologia 65, 763-776 (2022)
33.
Maalmi, H.* et al.: Serum neurofilament light chain: A novel biomarker for early diabetic sensorimotor polyneuropathy. Diabetologia 66, 579-589 (2022)
34.
Meyhöfer, S.* et al.: Sleep deprivation prevents counterregulatory adaptation to recurrent hypoglycaemia. Diabetologia 65, 1212-1221 (2022)
35.
Morgenstern, J.* et al.: Correction to: Neuron-specific biomarkers predict hypo- and hyperalgesia in individuals with diabetic peripheral neuropathy. Diabetologia 65:257 (2022)
36.
Ng, K.* et al.: Quantifying the utility of islet autoantibody levels in the prediction of type 1 diabetes in children. Diabetologia 66, 93-104 (2022)
37.
Sola-Gazagnes, A.* et al.: Insulin allergy: A diagnostic and therapeutic strategy based on a retrospective cohort and a case–control study. Diabetologia 65, 1278-1290 (2022)
38.
Weiss, A. et al.: Progression likelihood score identifies substages of presymptomatic type 1 diabetes in childhood public health screening. Diabetologia 65, 93-104 (2022)
39.
Weiss, A. et al.: Correction to: Progression likelihood score identifies substages of presymptomatic type 1 diabetes in childhood public health screening. Diabetologia, DOI: 10.1007/s00125-022-05798-z (2022)
40.
Woelfle, T.* et al.: Health impact of seven herpesviruses on (pre)diabetes incidence and HbA1c: Results from the KORA cohort. Diabetologia 65, 1328-1338 (2022)
▮◀ ◀◀ 1 ... 2 ... 3 ... 4 ... 5 ... 6 ... 7 ... 8 ... 9 ... 10 ... 11 ... 12 ... 13 ... 14 ... ▶▶ ▶▮